US Stock MarketDetailed Quotes

AIM AIM ImmunoTech

Watchlist
  • 0.2446
  • -0.0052-2.08%
Close Nov 7 16:00 ET
  • 0.2578
  • +0.0132+5.40%
Post 18:06 ET
15.49MMarket Cap-429P/E (TTM)

AIM ImmunoTech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
19.05%50K
-18.37%40K
43.26%202K
16.07%65K
119.05%46K
40.00%42K
48.48%49K
4.44%141K
12.00%56K
-36.36%21K
Operating revenue
19.05%50K
-18.37%40K
43.26%202K
16.07%65K
119.05%46K
40.00%42K
48.48%49K
4.44%141K
12.00%56K
-36.36%21K
Cost of revenue
8K
8K
42K
12K
30K
0
0
0
0
0
Gross profit
0.00%42K
-34.69%32K
13.48%160K
-5.36%53K
-23.81%16K
207.69%42K
211.36%49K
119.72%141K
144.44%56K
116.94%21K
Operating expense
-32.11%3.74M
32.73%5.77M
59.87%32.08M
150.48%14.06M
24.93%8.17M
18.19%5.5M
39.77%4.34M
22.76%20.06M
1.30%5.61M
71.93%6.54M
Selling and administrative expenses
1.61%2.59M
66.45%3.82M
61.67%21.14M
209.76%10.86M
5.20%5.44M
16.92%2.55M
10.62%2.29M
50.76%13.07M
33.93%3.51M
187.38%5.17M
-General and administrative expense
1.61%2.59M
66.45%3.82M
61.67%21.14M
209.76%10.86M
5.20%5.44M
16.92%2.55M
10.62%2.29M
50.76%13.07M
33.93%3.51M
187.38%5.17M
Research and development costs
-61.23%1.15M
-4.92%1.95M
56.49%10.94M
51.87%3.2M
99.27%2.73M
19.31%2.95M
98.07%2.05M
-8.89%6.99M
-27.92%2.11M
-31.61%1.37M
Operating profit
32.36%-3.69M
-33.50%-5.73M
-60.20%-31.92M
-152.05%-14M
-25.09%-8.16M
-16.32%-5.46M
-36.26%-4.3M
-16.79%-19.92M
1.94%-5.56M
-65.97%-6.52M
Net non-operating interest income expense
655.03%2.4M
-95.48%9K
69.95%1.07M
-22.52%258K
70.93%294K
302.53%318K
342.22%199K
1,038.81%629K
433.00%333K
960.00%172K
Non-operating interest income
711.32%2.58M
-59.30%81K
69.95%1.07M
-22.52%258K
70.93%294K
302.53%318K
342.22%199K
--629K
433.00%333K
--172K
Non-operating interest expense
--179K
--72K
----
----
----
--0
--0
----
----
----
Other net income (expense)
-332.05%-543K
-121.15%-92K
1,348.34%1.89M
40.29%1.17M
230.56%47K
199.57%234K
161.01%435K
92.45%-151K
1,142.50%834K
-129.27%-36K
Gain on sale of security
-477.66%-543K
-145.32%-92K
112.17%200K
345.56%401K
14.84%-310K
79.87%-94K
122.48%203K
-2,835.71%-1.64M
215.38%90K
-813.73%-364K
Special income (charges)
--0
--0
500.00%18K
-33.33%2K
--39K
--0
---23K
100.07%3K
100.17%3K
--0
-Gain on sale of property,plant,equipment
--0
--0
500.00%18K
-33.33%2K
--39K
--0
---23K
-98.61%3K
--3K
--0
Other non- operating income (expenses)
----
----
11.88%1.67M
3.51%767K
-3.05%318K
41.38%328K
34.21%255K
-35.75%1.49M
-58.30%741K
355.56%328K
Income before tax
62.60%-1.84M
-58.89%-5.82M
-48.94%-28.96M
-186.53%-12.58M
-22.41%-7.82M
-1.20%-4.91M
4.16%-3.66M
-1.66%-19.45M
24.92%-4.39M
-66.88%-6.39M
Income tax
Net income
62.60%-1.84M
-58.89%-5.82M
-48.94%-28.96M
-186.53%-12.58M
-22.41%-7.82M
-1.20%-4.91M
4.16%-3.66M
-1.66%-19.45M
24.92%-4.39M
-66.88%-6.39M
Net income continuous Operations
62.60%-1.84M
-58.89%-5.82M
-48.94%-28.96M
-186.53%-12.58M
-22.41%-7.82M
-1.20%-4.91M
4.16%-3.66M
-1.66%-19.45M
24.92%-4.39M
-66.88%-6.39M
Minority interest income
Net income attributable to the parent company
62.60%-1.84M
-58.89%-5.82M
-48.94%-28.96M
-186.53%-12.58M
-22.41%-7.82M
-1.20%-4.91M
4.16%-3.66M
-1.66%-19.45M
24.92%-4.39M
-66.88%-6.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
62.60%-1.84M
-58.89%-5.82M
-48.94%-28.96M
-186.53%-12.58M
-22.41%-7.82M
-1.20%-4.91M
4.16%-3.66M
-1.66%-19.45M
24.92%-4.39M
-66.88%-6.39M
Basic earnings per share
70.00%-0.03
-50.00%-0.12
-50.00%-0.6
-188.89%-0.26
-23.08%-0.16
0.00%-0.1
0.00%-0.08
0.00%-0.4
25.00%-0.09
-62.50%-0.13
Diluted earnings per share
70.00%-0.03
-50.00%-0.12
-50.00%-0.6
-188.89%-0.26
-23.08%-0.16
0.00%-0.1
0.00%-0.08
0.00%-0.4
25.00%-0.09
-62.50%-0.13
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 19.05%50K-18.37%40K43.26%202K16.07%65K119.05%46K40.00%42K48.48%49K4.44%141K12.00%56K-36.36%21K
Operating revenue 19.05%50K-18.37%40K43.26%202K16.07%65K119.05%46K40.00%42K48.48%49K4.44%141K12.00%56K-36.36%21K
Cost of revenue 8K8K42K12K30K00000
Gross profit 0.00%42K-34.69%32K13.48%160K-5.36%53K-23.81%16K207.69%42K211.36%49K119.72%141K144.44%56K116.94%21K
Operating expense -32.11%3.74M32.73%5.77M59.87%32.08M150.48%14.06M24.93%8.17M18.19%5.5M39.77%4.34M22.76%20.06M1.30%5.61M71.93%6.54M
Selling and administrative expenses 1.61%2.59M66.45%3.82M61.67%21.14M209.76%10.86M5.20%5.44M16.92%2.55M10.62%2.29M50.76%13.07M33.93%3.51M187.38%5.17M
-General and administrative expense 1.61%2.59M66.45%3.82M61.67%21.14M209.76%10.86M5.20%5.44M16.92%2.55M10.62%2.29M50.76%13.07M33.93%3.51M187.38%5.17M
Research and development costs -61.23%1.15M-4.92%1.95M56.49%10.94M51.87%3.2M99.27%2.73M19.31%2.95M98.07%2.05M-8.89%6.99M-27.92%2.11M-31.61%1.37M
Operating profit 32.36%-3.69M-33.50%-5.73M-60.20%-31.92M-152.05%-14M-25.09%-8.16M-16.32%-5.46M-36.26%-4.3M-16.79%-19.92M1.94%-5.56M-65.97%-6.52M
Net non-operating interest income expense 655.03%2.4M-95.48%9K69.95%1.07M-22.52%258K70.93%294K302.53%318K342.22%199K1,038.81%629K433.00%333K960.00%172K
Non-operating interest income 711.32%2.58M-59.30%81K69.95%1.07M-22.52%258K70.93%294K302.53%318K342.22%199K--629K433.00%333K--172K
Non-operating interest expense --179K--72K--------------0--0------------
Other net income (expense) -332.05%-543K-121.15%-92K1,348.34%1.89M40.29%1.17M230.56%47K199.57%234K161.01%435K92.45%-151K1,142.50%834K-129.27%-36K
Gain on sale of security -477.66%-543K-145.32%-92K112.17%200K345.56%401K14.84%-310K79.87%-94K122.48%203K-2,835.71%-1.64M215.38%90K-813.73%-364K
Special income (charges) --0--0500.00%18K-33.33%2K--39K--0---23K100.07%3K100.17%3K--0
-Gain on sale of property,plant,equipment --0--0500.00%18K-33.33%2K--39K--0---23K-98.61%3K--3K--0
Other non- operating income (expenses) --------11.88%1.67M3.51%767K-3.05%318K41.38%328K34.21%255K-35.75%1.49M-58.30%741K355.56%328K
Income before tax 62.60%-1.84M-58.89%-5.82M-48.94%-28.96M-186.53%-12.58M-22.41%-7.82M-1.20%-4.91M4.16%-3.66M-1.66%-19.45M24.92%-4.39M-66.88%-6.39M
Income tax
Net income 62.60%-1.84M-58.89%-5.82M-48.94%-28.96M-186.53%-12.58M-22.41%-7.82M-1.20%-4.91M4.16%-3.66M-1.66%-19.45M24.92%-4.39M-66.88%-6.39M
Net income continuous Operations 62.60%-1.84M-58.89%-5.82M-48.94%-28.96M-186.53%-12.58M-22.41%-7.82M-1.20%-4.91M4.16%-3.66M-1.66%-19.45M24.92%-4.39M-66.88%-6.39M
Minority interest income
Net income attributable to the parent company 62.60%-1.84M-58.89%-5.82M-48.94%-28.96M-186.53%-12.58M-22.41%-7.82M-1.20%-4.91M4.16%-3.66M-1.66%-19.45M24.92%-4.39M-66.88%-6.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 62.60%-1.84M-58.89%-5.82M-48.94%-28.96M-186.53%-12.58M-22.41%-7.82M-1.20%-4.91M4.16%-3.66M-1.66%-19.45M24.92%-4.39M-66.88%-6.39M
Basic earnings per share 70.00%-0.03-50.00%-0.12-50.00%-0.6-188.89%-0.26-23.08%-0.160.00%-0.10.00%-0.080.00%-0.425.00%-0.09-62.50%-0.13
Diluted earnings per share 70.00%-0.03-50.00%-0.12-50.00%-0.6-188.89%-0.26-23.08%-0.160.00%-0.10.00%-0.080.00%-0.425.00%-0.09-62.50%-0.13
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Cannabis & Hemp
Cannabis & Hemp
Intraday-0.54%